Open AccessHumoral immune response in healthcare workers after two doses of a BNT162b2 mRNA vaccine in Yucatan, Mexico
Author(s) -
FigueroaHurtado Esperanza,
OrtízFarias Diana Lizbeth,
SadaOvalle Isabel,
MaldonadoOrtíz Sandra Yareth,
ValdiviesoJiménez Jorge Arturo,
CortesTelles Arturo
Publication year - 2022
Publication title -
respirology case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.304
H-Index - 9
ISSN - 2051-3380
DOI - 10.1002/rcr2.920
Subject(s) - vaccination , medicine , immune system , serology , antibody response , immunology , adverse effect , antibody , titer , health care , covid-19 , virology , disease , infectious disease (medical specialty) , economics , economic growth
The antibody response to severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) as well as the host immune response after vaccination and viral infection have shown to be highly heterogeneous. This is a case series study analysing humoral immune response and vaccination side effects after two doses of a BNT162b2 mRNA among healthcare workers (HCWs) in Mexico. All participants were scheduled for their two doses of mRNA BNT162b2 vaccine and provided information through a questionnaire: demographic characteristics, antibody serum titres and vaccination‐related side effects. Blood samples were obtained for serology testing after the first and second doses of vaccine. No serious adverse effects due to vaccination were reported; nonetheless, non‐medical HCWs reported more side effects after the second dose. The previous infection with SARS‐CoV‐2 boosted immune response after receiving the first vaccination (roughly 30 times higher than those without previous infection); nonetheless, after the second dose, the immune response did not show a higher titre as might be expected.